Spotlight on landmark oncology trials: the latest evidence and novel trial designs

Overview of attention for article published in BMC Medicine, June 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 57 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer

Article in Oncology Letters (April 2022)

CHAPTER 15 Precision Oncology

Book chapter (January 2020)

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer

Article in Frontiers in Oncology (April 2018)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.